Regulation of lipid storage and inflammation in the liver by CEACAM1
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14338 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Sonia M Najjar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and the Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA. Hauptthemen laut MEDLINE: Antigens, CD, Liver, Cell Adhesion Molecules, Lipid Metabolism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
This review focuses on a special aspect of hepatic lipid storage and inflammation that occurs during nutritional excess in obesity. Mounting evidence supports that prolonged excess fatty acid (FA) uptake in the liver is strongly associated with hepatic lipid storage and inflammation and that the two processes are closely linked by a homeostatic mechanism. There is also strong evidence that bacterial lipids may enter the gut by a common mechanism with lipid absorption and that there is a set point to determine when their uptake triggers an inflammatory response in the liver. In fact, the progression from high uptake of FAs in the liver resulting in Metabolic dysfunction‐associated steatotic liver disease (MASLD) to the development of the more serious Metabolic dysfunction‐associated steatohepatitis (MASH) depends on the degree of inflammation and its progression from an acute to a chronic state. Thus, MASLD/MASH implicates both excess fatty acids and progressive inflammation in the aetiology of liver disease. We start the discussion by introduction of CD36, a major player in FA and lipopolysaccharide (LPS) uptake in the duodenum, liver and adipose tissue. We will then introduce CEACAM1, a major player in the regulation of hepatic de novo lipogenesis and the inflammatory response in the liver, and its dual association with CD36 in enterocytes and hepatocytes. We conclude that CEACAM1 and CD36 together regulate lipid droplet formation and inflammation in the liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences and the Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
- Department of Immunology and Theranostics, Arthur D. Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA.
ORCID-Profile: John E Shively
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Najjar, S. M., & Shively, J. E. (2024). Regulation of lipid storage and inflammation in the liver by CEACAM1. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14338
Vancouver
Najjar SM, Shively JE. Regulation of lipid storage and inflammation in the liver by CEACAM1. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14338
BibTeX
@article{Najjar2024,
author = {Najjar, Sonia M and Shively, John E},
title = {Regulation of lipid storage and inflammation in the liver by CEACAM1},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14338}
}
EUVIMED